---
title: "Medtide proposes bylaw changes to allow board size range of five to nine directors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297149727.md"
description: "Medtide Inc. has proposed bylaw changes to allow its board size to range from five to nine directors, replacing the previous fixed number of nine, while maintaining at least three independent non-executive directors. The proposal also broadens the definition of senior management and tightens shareholder meeting notice requirements, raising the AGM notice period to at least 21 days. These changes are pending shareholder approval at an Extraordinary General Meeting."
datetime: "2026-08-27T08:40:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297149727.md)
  - [en](https://longbridge.com/en/news/297149727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297149727.md)
generator: "portal-rs"
---

# Medtide proposes bylaw changes to allow board size range of five to nine directors

-   Medtide unveiled bylaw changes covering its Articles of Association plus board and shareholder-meeting procedure rules, pending shareholder votes at an EGM. \* Board size range set at five to nine directors, from a fixed nine, while keeping at least three independent non-executive directors. \* Senior management definition broadened to add other executives appointed by the board, with “financial controller” revised to chief financial officer. \* Shareholder-meeting rules tightened on notice timing, raising AGM notice to at least 21 days via announcement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtide Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12301788), on August 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03880.HK](https://longbridge.com/en/quote/03880.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Medtide amends articles of association, scraps supervisory committee](https://longbridge.com/en/news/290190278.md)
- [Medtide unit Chinese Peptide completes US FDA pre-license inspection for Hepcludex API facility](https://longbridge.com/en/news/294479988.md)
- [Hangzhou Jiuyuan Gene Engineering announces extraordinary general meeting](https://longbridge.com/en/news/297489912.md)
- [Micot Pharma Reports Positive Operating Cash Flow and Advances Late-Stage Pipeline in 1H 2026](https://longbridge.com/en/news/297506614.md)
- [Hangzhou Tigermed Consulting Co., Ltd. Class H (5HZ1) was downgraded to a Hold Rating at Jefferies](https://longbridge.com/en/news/297787043.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**